vs

Side-by-side financial comparison of United Homes Group, Inc. (UHG) and Viridian Therapeutics, Inc.\DE (VRDN). Click either name above to swap in a different company.

United Homes Group, Inc. is the larger business by last-quarter revenue ($123.4M vs $70.6M, roughly 1.7× Viridian Therapeutics, Inc.\DE). United Homes Group, Inc. runs the higher net margin — 2.6% vs -49.0%, a 51.6% gap on every dollar of revenue. On growth, Viridian Therapeutics, Inc.\DE posted the faster year-over-year revenue change (81958.1% vs -8.5%). United Homes Group, Inc. produced more free cash flow last quarter ($616.0K vs $-84.7M).

Invitation Homes Inc. is a public company traded on the New York Stock Exchange. It is headquartered in the Lincoln Center building in Dallas, Texas. Dallas B. Tanner is chief executive officer. As of 2017, the company was reportedly the largest owner of single-family rental homes in the United States. As of July 2024, the company owned about 84,000 rental homes in 16 markets. Seventeen percent of their rental income is from California.

Viridian Therapeutics is a clinical-stage biotechnology firm developing novel disease-modifying therapies for rare, serious autoimmune and inflammatory diseases. Its lead pipeline candidate targets thyroid eye disease, a debilitating orbital disorder, with primary market focus on North America and Europe.

UHG vs VRDN — Head-to-Head

Bigger by revenue
UHG
UHG
1.7× larger
UHG
$123.4M
$70.6M
VRDN
Growing faster (revenue YoY)
VRDN
VRDN
+81966.6% gap
VRDN
81958.1%
-8.5%
UHG
Higher net margin
UHG
UHG
51.6% more per $
UHG
2.6%
-49.0%
VRDN
More free cash flow
UHG
UHG
$85.4M more FCF
UHG
$616.0K
$-84.7M
VRDN

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
UHG
UHG
VRDN
VRDN
Revenue
$123.4M
$70.6M
Net Profit
$3.2M
$-34.6M
Gross Margin
17.5%
Operating Margin
1.3%
-56.7%
Net Margin
2.6%
-49.0%
Revenue YoY
-8.5%
81958.1%
Net Profit YoY
380.4%
54.9%
EPS (diluted)
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
UHG
UHG
VRDN
VRDN
Q4 25
$123.4M
Q3 25
$90.8M
$70.6M
Q2 25
$105.5M
Q1 25
$87.0M
Q4 24
$134.8M
Q3 24
$118.6M
Q2 24
$109.4M
Q1 24
$100.8M
Net Profit
UHG
UHG
VRDN
VRDN
Q4 25
$3.2M
Q3 25
$-31.3M
$-34.6M
Q2 25
$-6.3M
Q1 25
$18.2M
Q4 24
$667.0K
Q3 24
$-7.3M
Q2 24
$28.6M
Q1 24
$24.9M
Gross Margin
UHG
UHG
VRDN
VRDN
Q4 25
17.5%
Q3 25
17.7%
Q2 25
18.9%
Q1 25
16.2%
Q4 24
16.2%
Q3 24
18.9%
Q2 24
17.9%
Q1 24
16.0%
Operating Margin
UHG
UHG
VRDN
VRDN
Q4 25
1.3%
Q3 25
-1.7%
-56.7%
Q2 25
1.8%
Q1 25
-2.3%
Q4 24
1.8%
Q3 24
3.1%
Q2 24
-0.0%
Q1 24
-1.0%
Net Margin
UHG
UHG
VRDN
VRDN
Q4 25
2.6%
Q3 25
-34.5%
-49.0%
Q2 25
-6.0%
Q1 25
20.9%
Q4 24
0.5%
Q3 24
-6.2%
Q2 24
26.2%
Q1 24
24.7%
EPS (diluted)
UHG
UHG
VRDN
VRDN
Q4 25
$0.05
Q3 25
$-0.53
Q2 25
$-0.11
Q1 25
$0.31
Q4 24
$0.11
Q3 24
$-0.15
Q2 24
$0.50
Q1 24
$0.44

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
UHG
UHG
VRDN
VRDN
Cash + ST InvestmentsLiquidity on hand
$24.4M
$490.9M
Total DebtLower is stronger
$67.5M
Stockholders' EquityBook value
$57.4M
$503.0M
Total Assets
$276.6M
$577.1M
Debt / EquityLower = less leverage
1.18×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
UHG
UHG
VRDN
VRDN
Q4 25
$24.4M
Q3 25
$25.6M
$490.9M
Q2 25
$36.5M
Q1 25
$25.0M
Q4 24
$22.6M
Q3 24
$25.8M
Q2 24
$24.9M
Q1 24
$28.7M
Total Debt
UHG
UHG
VRDN
VRDN
Q4 25
$67.5M
Q3 25
$67.4M
Q2 25
$67.3M
Q1 25
$67.2M
Q4 24
$67.2M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
UHG
UHG
VRDN
VRDN
Q4 25
$57.4M
Q3 25
$52.9M
$503.0M
Q2 25
$82.2M
Q1 25
$87.1M
Q4 24
$66.9M
Q3 24
$19.8M
Q2 24
$25.7M
Q1 24
$-4.7M
Total Assets
UHG
UHG
VRDN
VRDN
Q4 25
$276.6M
Q3 25
$293.1M
$577.1M
Q2 25
$281.1M
Q1 25
$266.2M
Q4 24
$265.4M
Q3 24
$282.6M
Q2 24
$284.0M
Q1 24
$287.2M
Debt / Equity
UHG
UHG
VRDN
VRDN
Q4 25
1.18×
Q3 25
1.27×
Q2 25
0.82×
Q1 25
0.77×
Q4 24
1.00×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
UHG
UHG
VRDN
VRDN
Operating Cash FlowLast quarter
$1.4M
$-84.6M
Free Cash FlowOCF − Capex
$616.0K
$-84.7M
FCF MarginFCF / Revenue
0.5%
-120.1%
Capex IntensityCapex / Revenue
0.6%
0.2%
Cash ConversionOCF / Net Profit
0.44×
TTM Free Cash FlowTrailing 4 quarters
$-21.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
UHG
UHG
VRDN
VRDN
Q4 25
$1.4M
Q3 25
$-23.8M
$-84.6M
Q2 25
$1.6M
Q1 25
$1.2M
Q4 24
$27.4M
Q3 24
$7.2M
Q2 24
$-1.2M
Q1 24
$-17.9M
Free Cash Flow
UHG
UHG
VRDN
VRDN
Q4 25
$616.0K
Q3 25
$-24.8M
$-84.7M
Q2 25
$1.3M
Q1 25
$1.2M
Q4 24
$27.4M
Q3 24
$7.2M
Q2 24
Q1 24
$-17.9M
FCF Margin
UHG
UHG
VRDN
VRDN
Q4 25
0.5%
Q3 25
-27.3%
-120.1%
Q2 25
1.2%
Q1 25
1.4%
Q4 24
20.3%
Q3 24
6.1%
Q2 24
Q1 24
-17.8%
Capex Intensity
UHG
UHG
VRDN
VRDN
Q4 25
0.6%
Q3 25
1.1%
0.2%
Q2 25
0.2%
Q1 25
0.0%
Q4 24
0.0%
Q3 24
0.0%
Q2 24
0.0%
Q1 24
0.0%
Cash Conversion
UHG
UHG
VRDN
VRDN
Q4 25
0.44×
Q3 25
Q2 25
Q1 25
0.07×
Q4 24
41.09×
Q3 24
Q2 24
-0.04×
Q1 24
-0.72×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

UHG
UHG

GSH South Carolina$116.3M94%
Rosewood$5.9M5%
Other Segment$1.1M1%

VRDN
VRDN

Segment breakdown not available.

Related Comparisons